Martin Kulldorff speaks during a meeting of the Advisory Committee on Immunization Practices at the CDC (Mike Stewart/AP Images)
June 25, 2025 03:37 PM EDT
R&D
FDA+

Re­built CDC pan­el will re­assess cu­mu­la­tive vac­cine ef­fects, old­er shots

Max Bayer

Pharma Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump’s CDC nom­i­nee side­steps Sen­ate grilling on con­tro­ver­sial changes

Kymera inks deal with Gilead as part­ner­ship with Sanofi faces a switch-up

Ex­clu­sive: FDA's Makary sought re­jec­tion of KalVista’s drug in an un­usu­al move by com­mis­sion­er, sources say

Bright­Gene seeks a part­ner for Zep­bound-beat­ing obe­si­ty shot

FDA in­ves­ti­gat­ing Sarep­ta’s Duchenne gene ther­a­py fol­low­ing pa­tient deaths

sponsored

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

A service from the Financial Times